|
Dr Julian Chick appointed as Deputy Chair
|
27 June 2023 at 8:40am
|
|
Shareholder and Investor Webinar
|
26 June 2023 at 2:50pm
|
|
Letter to ineligible shareholders
|
23 June 2023 at 8:40am
|
|
Prospectus and Entitlement and Acceptance Form
|
23 June 2023 at 8:40am
|
|
Despatch of Prospectus and Entitlement and Acceptance Form
|
23 June 2023 at 8:40am
|
|
Cann signs significant variation with key customer
|
20 June 2023 at 1:25pm
|
|
S3 clinical trial update
|
15 June 2023 at 5:50pm
|
|
Update - Proposed issue of securities - CAN
|
15 June 2023 at 4:00pm
|
|
Target market determination
|
15 June 2023 at 10:20am
|
|
Prospectus
|
15 June 2023 at 10:20am
|
|
Proposed issue of securities - CAN
|
15 June 2023 at 10:15am
|
|
Material terms to lead manager options
|
15 June 2023 at 10:10am
|
|
Proposed issue of securities - CAN
|
15 June 2023 at 10:00am
|
|
Investor presentation
|
15 June 2023 at 10:00am
|
|
Non-renounceable entitlement offer
|
15 June 2023 at 9:50am
|
|
First Cann dried flower products cleared for sale in Germany
|
28 April 2023 at 4:30pm
|
|
Quarterly Activities and Appendix 4C Cashflow Report
|
27 April 2023 at 6:30pm
|
|
Investor Webinar Presentation
|
17 April 2023 at 11:25am
|
|
Shareholder Webinar
|
5 April 2023 at 4:55pm
|
|
Notification regarding unquoted securities - CAN
|
5 April 2023 at 4:05pm
|
|
Notification of cessation of securities - CAN
|
31 March 2023 at 10:45am
|
|
Cleansing statement
|
29 March 2023 at 4:10pm
|
|
Notification regarding unquoted securities - CAN
|
29 March 2023 at 3:25pm
|
|
Application for quotation of securities - CAN
|
27 March 2023 at 5:55pm
|
|
Southern facility - Land and building settlement
|
1 March 2023 at 12:35pm
|
|
Notification of cessation of securities - CAN
|
1 March 2023 at 10:30am
|
|
Half year results presentation
|
28 February 2023 at 11:20am
|
|
Application for quotation of securities - CAN
|
28 February 2023 at 8:15am
|
|
Cann Group half year results
|
24 February 2023 at 9:55am
|
|
Half Yearly Report and Accounts
|
24 February 2023 at 9:50am
|
|
Top 20 option holders
|
10 February 2023 at 10:55am
|
|
Appendix 3G - Options
|
10 February 2023 at 10:55am
|
|
Notification regarding unquoted securities - CAN
|
10 February 2023 at 10:20am
|
|
Issue of performance rights and options
|
10 February 2023 at 10:15am
|
|
Appendix 3H - Notification of cessation of securities
|
2 February 2023 at 9:40am
|
|
Application for quotation of securities - CAN
|
1 February 2023 at 5:30pm
|
|
Quarterly Activities and Appendix 4C Cashflow Report
|
30 January 2023 at 9:50am
|
|
S3 Trial update
|
19 January 2023 at 9:35am
|
|
Appointment of new CEO
|
10 January 2023 at 8:50am
|
|
Cann Group agrees terms for the sale of Southern facility
|
23 December 2022 at 11:25am
|
|
Change of Director's Interest Notice
|
7 December 2022 at 11:20am
|
|
Application for quotation of securities - CAN
|
7 December 2022 at 11:05am
|
|
Results of Share Purchase Plan offer
|
5 December 2022 at 10:30am
|
|
Close of Share Purchase Plan offer
|
1 December 2022 at 8:40am
|
|
Port Jackson Securities investor webinar presentation
|
25 November 2022 at 12:20pm
|
|
Port Jackson Securities webinar
|
23 November 2022 at 5:15pm
|
|
Final clinical trial participant completes study
|
21 November 2022 at 10:00am
|
|
Share Purchase Plan offer closing date extended
|
16 November 2022 at 7:35pm
|
|
Cann Group and Haleon sign non-binding term sheet
|
7 November 2022 at 9:40am
|
|
Cann Group Limited Investor Webinar
|
3 November 2022 at 8:35am
|
Cann Group